|
Vaccine Detail
Insulin-dependent diabetes mellitus DNA vaccine JwGAD65 + IL-4 |
Vaccine Information |
- Vaccine Name: Insulin-dependent diabetes mellitus DNA vaccine JwGAD65 + IL-4
- Target Pathogen: Diabetes
- Target Disease: Diabetes
- Vaccine Ontology ID: VO_0004406
- Type: DNA vaccine
- Status: Research
- Host Species as Laboratory Animal Model: Mouse
- Antigen: a fusion protein consisting of a portion of murine GAD65 and IgGFc (Tisch et al., 2001)
- Gad65
gene engineering:
- Type: DNA vaccine construction
- Description: Vector Jw4303 expressed a secreted fusion protein consisting of a fragment of glutamic acid decarboxylase 65 (GAD65) linked to IgGFc (Tisch et al., 2001).
- Detailed Gene Information: Click Here.
- IgG Fc
gene engineering:
- Type: DNA vaccine construction
- Description:
- Detailed Gene Information: Click Here.
- DNA vaccine plasmid:
- DNA vaccine plasmid name:
- DNA vaccine plasmid VO ID: VO_0000276
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Mouse Response
- Vaccine Immune Response Type: VO_0003057
- Efficacy: After monitoring animals up to 58 wk of age, the majority of unimmunized nonobese diabetic (NOD) mice (70%) or animals immunized with JwHEL + IL-4 (75%) or JwGAD65 (83%) had developed diabetes. In contrast, only 17% of NOD mice immunized with JwGAD65 + IL-4 developed diabetes (p = 0.03 vs unimmunized, p = 0.01 vs JwHEL + IL-4, χ2 test) (Tisch et al., 2001).
|
References |
Tisch et al., 2001: Tisch R, Wang B, Weaver DJ, Liu B, Bui T, Arthos J, Serreze DV. Antigen-specific mediated suppression of beta cell autoimmunity by plasmid DNA vaccination. Journal of immunology (Baltimore, Md. : 1950). 2001; 166(3); 2122-2132. [PubMed: 11160264].
|
|